US-based therapeutics device company Clarimedix secured an undisclosed amount of funding on Wednesday from the Johnson & Johnson Corporate Office of Science and Technology (COSAT), part of the pharmaceutical conglomerate’s website where innovators submit ideas to Johnson & Johnson operating companies..

Clarimedix focuses its research on disorders associated with blood vessel problems, Alzheimer’s disease among them. The technology used by Clarimedix involves a ligh-emitting diode (LED) patch that can be placed on the skin to trigger nitric oxide production in…